Use of adenosine, adenosine analogs or nucleoside uptake blocker

Details Use of adenosine, adenosine analogs or nucleoside uptake blocker Use of adenosine, adenosine analogs or nucleoside uptake blocker

1989-06-28

1991-12-24

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514258, A61K 3170, A61K 31505

Patent

active

050752901

ABSTRACT:
Infusion of adenosine, adenoside analogs and nucleoside uptake blockers, e.g. dipyridamole, will decrease the number of apneas and associated oxyhemoglobin desaturation during sleep in patients with obstructuve sleep apnea.

REFERENCES:
Chem. Abst. 106:189577 (1987), Radulovacki.
Biaggioni et al., Circ. Res. 61:779-786 (1987).
Maxwell et al., J. Appl. Physiol. 61:1762-1766 (1986).
Watt et al., Am. Rev. Respir. Dis. 136:755-761 (1987).

Affiliated with

Also associated with

Rating

Use of adenosine, adenosine analogs or nucleoside uptake blocker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of adenosine, adenosine analogs or nucleoside uptake blocker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine, adenosine analogs or nucleoside uptake blocker will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-43506